Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge-Reference-Cited by-同舟云学术

Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge

Published:2012-02 Issue:10 Volume:30 Page:1830-1840
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Cox Josephine H.,Ferrari Maria G.,Earl Patricia,Lane James R.,Jagodzinski Linda L.,Polonis Victoria R.,Kuta Ellen G.,Boyer Jean D.,Ratto-Kim Silvia,Eller Leigh-Anne,Pham Doan-Trang,Hart Lydia,Montefiori David,Ferrari Guido,Parrish Stephanie,Weiner David B.,Moss Bernard,Kim Jerome H.,Birx Deborah,VanCott Thomas C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference93 articles.

1. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;Buchbinder;Lancet,2008

2. HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine;Gilbert;J Infect Dis,2005

3. HIV-1 vaccine-induced immunity in the test-of-concept step study: a case-cohort analysis;McElrath;Lancet,2008

4. Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1;Pitisuttithum;J Acquir Immune Defic Syndr,2004

5. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;Rerks-Ngarm;N Engl J Med,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope;PLOS Pathogens;2023-10-25

2. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models;Expert Review of Vaccines;2017-09-04

3. HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV;Heliyon;2017-06

4. Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors;Vaccine;2017-05

5. New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design;Expert Review of Vaccines;2016-03-16